Literature DB >> 6515708

Falsely increased digoxin concentrations in samples from neonates and infants.

J M Hicks, E M Brett.   

Abstract

Several previous studies have suggested the presence of a digoxin-like immunoreactive substance in the serum of infants. In this study we examined eight different immunoassay kits to confirm the presence of such a substance. The kits were evaluated using serum from newborns and infants who were not receiving digoxin. We investigated the relationship of this digoxin-like immunoreactive substance to substances that are present in unusual concentrations in newborn sera. These substances included fatty acids, cholesterol, triglycerides, bilirubin, protein, and albumin. No relationship could be established. Since serum steroid concentrations are known to be increased in the newborn and since digoxin is essentially a steroid derivative, we looked at steroids separately and collectively to see whether they mimicked the immunoreactivity of digoxin. We found that pooled steroids did indeed mimic digoxin and might be implicated as the immunoreactive substances.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6515708     DOI: 10.1097/00007691-198412000-00015

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  9 in total

1.  Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.

Authors:  R G Morris; D B Frewin; N C Saccoia; W L Goldsworthy; W S Jeffries; A J McPhee
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Sodium transport inhibitors in pregnancy-induced hypertension.

Authors:  L Poston
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 3.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 4.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

5.  Therapeutic drug monitoring.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

6.  Renal disease and digoxin immunoassays.

Authors:  N Capps
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-07

7.  Endogenous digoxin-like immunoreactivity during pregnancy and at birth.

Authors:  J M Lupoglazoff; E Jacqz-Aigrain; B Guyot; O Chappey; P Blot
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

Review 8.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

Review 9.  Overview of therapeutic drug monitoring.

Authors:  Ju Seop Kang; Min Ho Lee
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 3.165

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.